Noninvasive Respiratory Assist Devices in the Management of COVID-19-related Hypoxic Respiratory Failure: Pune ISCCM COVID-19 ARDS Study Consortium (PICASo).

Autor: Jog, Sameer, Zirpe, Kapil, Dixit, Subhal, Godavarthy, Purushotham, Shahane, Manasi, Kadapatti, Kayanoosh, Shah, Jignesh, Borawake, Kapil, Khan, Zafer, Shukla, Urvi, Jahagirdar, Ashwini, Dhat, Venkatesh, D'costa, Pradeep, Shelgaonkar, Jayant, Deshmukh, Abhijit, Khatib, Khalid, Prayag, Shirish
Předmět:
Zdroj: Indian Journal of Critical Care Medicine; Jul2022, Vol. 26 Issue 7, p791-797, 7p, 1 Diagram, 3 Charts, 1 Graph
Abstrakt: Objective: To determine whether high-flow nasal oxygen (HFNO) or noninvasive ventilator (NIV) can avoid invasive mechanical ventilation (IMV) in COVID-19-related acute respiratory distress syndrome (ADRS), and the outcome predictors of these modalities. Design: Multicenter retrospective study conducted in 12 ICUs in Pune, India. Patients: Patients with COVID-19 pneumonia who had PaO2/FiO2 ratio <150 and were treated with HFNO and/or NIV. Intervention: HFNO and/or NIV. Measurements: The primary outcome was to assess the need of IMV. Secondary outcomes were death at Day 28 and mortality rates in different treatment groups. Main results: Among 1,201 patients who met the inclusion criteria, 35.9% (431/1,201) were treated successfully with HFNO and/or NIV and did not require IMV. About 59.5% (714/1,201) patients needed IMV for the failure of HFNO and/or NIV. About 48.3, 61.6, and 63.6% of patients who were treated with HFNO, NIV, or both, respectively, needed IMV. The need of IMV was significantly lower in the HFNO group (p <0.001). The 28-day mortality was 44.9, 59.9, and 59.6% in the patients treated with HFNO, NIV, or both, respectively (p <0.001). On multivariate regression analysis, presence of any comorbidity, SpO2 <90%, and presence of nonrespiratory organ dysfunction were independent and significant determinants of mortality (p <0.05). Conclusions: During COVID-19 pandemic surge, HFNO and/or NIV could successfully avoid IMV in 35.5% individuals with PO2/FiO2 ratio <150. Those who needed IMV due to failure of HFNO or NIV had high (87.5%) mortality. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index